ActHIB
HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN · KIT · Sanofi Vaccines US Inc.
ActHIB is a kit containing haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen. Manufactured by Sanofi Vaccines US Inc..
Key Facts
- Brand Name
- ActHIB
- Generic Name
- HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
- NDC Code (Product)
49281-545- Manufacturer
- Sanofi Vaccines US Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA103935
- Marketing Start
- 03/30/1993
Recall History
No Recall HistoryFrequently Asked Questions
What is ActHIB used for?
ActHIB contains HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN. It is a kit taken as directed. Consult your doctor for specific uses.
Is ActHIB a controlled substance?
ActHIB is not classified as a controlled substance by the DEA.
What is the generic name for ActHIB?
The generic name for ActHIB is HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN. There are no other listed brand versions of HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN.
What is the NDC code for ActHIB ?
The NDC (National Drug Code) for ActHIB is 49281-545, listed by Sanofi Vaccines US Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)